Literature DB >> 33422108

Increased O-GlcNAcylation of Drp1 by amyloid-beta promotes mitochondrial fission and dysfunction in neuronal cells.

So Jung Park1, Ji-Eun Bae2, Doo Sin Jo3, Joon Bum Kim3, Na Yeon Park3, Jianguo Fang4, Yong-Keun Jung5, Dong Gyu Jo6, Dong-Hyung Cho7,8.   

Abstract

As a dynamic organelle, mitochondria continuously fuse and divide with adjacent mitochondria. Imbalance in mitochondria dynamics leads to their dysfunction, which implicated in neurodegenerative diseases. However, how mitochondria alteration and glucose defect contribute to pathogenesis of Alzheimer's disease (AD) is still largely unknown. Dynamin-related protein 1 (Drp1) is an essential regulator for mitochondria fission. Among various posttranslational modifications, O-GlcNAcylation plays a role as a sensor for nutrient and oxidative stress. In this study, we identified that Drp1 is regulated by O-GlcNAcylation in AD models. Treatment of Aβ as well as PugNAc resulted in mitochondrial fragmentation in neuronal cells. Moreover, we found that AD mice brain exhibits an upregulated Drp1 O-GlcNAcylation. However, depletion of OGT inhibited Drp1 O-GlcNAcylation in Aβ-treated cells. In addition, overexpression of O-GlcNAc defective Drp1 mutant (T585A and T586A) decreased Drp1 O-GlcNAcylation and Aβ-induced mitochondria fragmentation. Taken together, these finding suggest that Aβ regulates mitochondrial fission by increasing O-GlcNAcylation of Drp1.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-beta; Drp1; Mitochondrial fission; O-GlcNAcylation

Year:  2021        PMID: 33422108     DOI: 10.1186/s13041-020-00727-w

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


  3 in total

1.  OGT Regulates Mitochondrial Biogenesis and Function via Diabetes Susceptibility Gene Pdx1.

Authors:  Ramkumar Mohan; Seokwon Jo; Amber Lockridge; Deborah A Ferrington; Kevin Murray; Arthur Eschenlauer; Ernesto Bernal-Mizrachi; Yoshio Fujitani; Emilyn U Alejandro
Journal:  Diabetes       Date:  2021-08-30       Impact factor: 9.461

Review 2.  Mitochondrial Regulation of Diabetic Kidney Disease.

Authors:  Daniel L Galvan; Koki Mise; Farhad R Danesh
Journal:  Front Med (Lausanne)       Date:  2021-09-27

Review 3.  Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Luis F González; Lorenzo E Bevilacqua; Rodrigo Naves
Journal:  Pharmaceutics       Date:  2021-12-01       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.